Natera (NTRA) announced that Obstetrics & Gynecology published the company’s clinical validation study on its cell-free DNA, or cfDNA, ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that Obstetrics & ...

Figure 1: AZFa region of the human Y chromosome. Figure 2: De novo deletion at USP9Y splice-donor site in azoospermic man WHT2780.

However, about 61 million years ago, a pivotal change occurred. GULOP ceased to function, transforming into a ‘pseudogene,’ a ghostly reminder of a capability we once possessed. This genetic ...

To comprehensively survey receptor expression, we also included VR and OR pseudogenes in our analysis (Fig. S8B-G). We did not detect a significant expression of pseudogene V1Rs (Figs. S8B and S8E), ...